Skip to main content
Drug misuse and dependency

Policy papers and consultations

Skip to results

55 results

Skip to results
55 results sorted by Updated (newest)
  • Expanding access to naloxone: supply and emergency use

    This consultation seeks views on proposals to make further legislative changes to expand access to take-home naloxone supplies and naloxone for emergency use.

    • From: Department of Health and Social Care and 3 others
    • Updated:
  • Drug use in LGBT+ communities and chemsex

    The Advisory Council on the Misuse of Drugs (ACMD) is reviewing the evidence of drug use in LGBT+ communities and in the context of chemsex in the UK.

    • From: Advisory Council on the Misuse of Drugs
    • Updated:
  • Cannabis-based products for medicinal use

    Call for evidence to support ACMD's review of changes to legislation on the use of cannabis-based products for medicinal purposes (CBPMs).

    • From: Advisory Council on the Misuse of Drugs
    • Updated:
  • The misuse and harms of gabapentin and pregabalin

    Call for evidence to support ACMD's review of the misuse and harms of gabapentin and pregabalin.

    • From: Advisory Council on the Misuse of Drugs
    • Updated:
  • Ketamine harms assessment

    The Advisory Council on the Misuse of Drugs (ACMD) is calling for evidence on ketamine use, harms and interventions.

    • From: Advisory Council on the Misuse of Drugs
    • Updated:
  • Proposals to expand access to take-home naloxone supplies

    The UK Government is consulting on proposed legislative amendments to widen access to take-home supplies of naloxone, without a prescription.

    • From: Department of Health and Social Care and 3 others
    • Updated:

    First published during the 2022 to 2024 Sunak Conservative government

  • Expanding access to naloxone

    This consultation collected views on expanding the use of naloxone. It ran for 8 weeks and was open to all interested individuals and organisations.

    • From: Department of Health and Social Care
    • Updated:

    First published during the 2019 to 2022 Johnson Conservative government

  • Drug prevention policies and landscape across the UK

    The Advisory Council on the Misuse of Drugs (ACMD) seeks to gather insight into current government-led drug prevention policies and landscape across the UK.

    • From: Home Office and 1 others
    • Updated:

    First published during the 2022 to 2024 Sunak Conservative government

  • ACMD internet-facilitated drug markets review

    The Advisory Council on the Misuse of Drugs call for evidence, collecting written evidence to better understand internet-facilitated drug markets (IFDMs).

    • From: Home Office and 1 others
    • Updated:

    First published during the 2022 to 2024 Sunak Conservative government

  • Drug use in ethnic minority groups

    The ACMD will use your response to help them formulate advice to government about drug use in ethnic minority groups.

    • From: Home Office and 1 others
    • Updated:

    First published during the 2022 to 2024 Sunak Conservative government

  • Nitrous oxide: legitimate uses and appropriate controls

    We are seeking views to enable us to determine legitimate uses of nitrous oxide.

    • From: Home Office
    • Updated:

    First published during the 2022 to 2024 Sunak Conservative government

  • From harm to hope: A 10-year drugs plan to cut crime and save lives

    A 10-year plan to cut crime and save lives by reducing the supply and demand for drugs and delivering a high-quality treatment and recovery system.

    • From: Home Office and 5 others
    • Updated:

    First published during the 2019 to 2022 Johnson Conservative government

  • Independent review of drugs: call for evidence, part 2

    An independent review into the use and supply of illicit drugs, seeking views on how to reduce harm to individuals and society.

    • From: Department of Health and Social Care
    • Updated:

    First published during the 2019 to 2022 Johnson Conservative government

  • ACMD ageing cohort of drug users report: government response

    The government's response to the Advisory Council on the Misuse of Drugs (ACMD) report 'Ageing cohort of drug users'.

    • From: Department of Health and Social Care
    • Updated:

    First published during the 2019 to 2022 Johnson Conservative government

  • NDTMS annual reports and methodology: proposed changes

    Consultation about changes to the national drug treatment monitoring system (NDTMS) annual reports format and the methodology for the young people's report.

    • From: Public Health England
    • Updated:
  • Drug related harms in homeless populations: government response

    Government response to recommendations from the Advisory Council on the Misuse of Drugs.

    • From: Ministry of Housing, Communities & Local Government (2018 to 2021) and 1 others
    • Updated:

    First published during the 2019 to 2022 Johnson Conservative government

  • Drugs policy and medicinal cannabis report: government response

    The government's response to the Health and Social Care Committee's report.

    • From: Department of Health and Social Care
    • Updated:

    First published during the 2019 to 2022 Johnson Conservative government

  • NDTMS criminal justice intervention teams dataset: proposed changes

    We're inviting feedback on proposed changes to the criminal justice intervention teams dataset collected for the national drug treatment monitoring system.

    • From: Public Health England
    • Updated:
  • Prescribed medicines review: expert group terms of reference

    Terms of reference of the expert reference group advising the review of prescribed medicines.

    • From: Public Health England
    • Updated:
  • Drug strategy 2017

    The drug strategy 2017 sets out how the government and its partners, at local, national and international levels, will take new action to tackle drug misuse and the harms it causes.

    • From: Home Office
    • Updated:

    First published during the 2016 to 2019 May Conservative government